Use of loteprednol etabonate for the treatment of dry eye

Details for Australian Patent Application No. 2005229006 (hide)

Owner Bausch & Lomb Incorporated

Inventors Bartels, Stephen P.

Agent Spruson & Ferguson

Pub. Number AU-B-2005229006

PCT Pub. Number WO2005/094836

Priority 60/556,161 25.03.04 US

Filing date 24 March 2005

Wipo publication date 13 October 2005

Acceptance publication date 20 January 2011

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/094836 Priority application(s): WO2005/094836

20 January 2011 Application Accepted

  Published as AU-B-2005229006

19 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005229007-Constrained artificial implant for orthopaedic applications

2005229001-Chemically modified protein compositions and methods